Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Hyderabad India (2003)

Organization Overview

First Clinical Trial
2010
NCT02282800
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Garlapati Komali | panineeya institute of dental sciences and research center | Panineeya Mahavidhyalaya Institute of Dental Sciences | Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre | PG Student | PMVIDS & RC

Active Ingredients

Drugs in Phase 4 Trials (4)

alendronic acid (fosamax) (1 trial)

calcium phosphate (1 trial)

clarithromycin (biaxin) (1 trial)

diclofenac (voltaren) (1 trial)

Drugs in Phase 3 Trials (2)

multivitamins (1 trial)

vitamin c (1 trial)

Drugs in Phase 2 Trials (2)

betamethasone (celestone) (1 trial)

clobetasol (dermovate) (1 trial)

Drugs in Other Trials (2)

hyaluronic acid (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Facial Pain (Phase 4)

Head and Neck Neoplasms (Phase 3)

Lichen Planus (Phase 2)

Lichen Planus, Oral (Phase 2)

Mucositis (Phase 3)

Periodontitis (Phase 4)

Stomatitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 10